SELLAS Life Sciences (SLS) Total Current Liabilities (2019 - 2024)
Historic Total Current Liabilities for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to $10.6 million.
- SELLAS Life Sciences' Total Current Liabilities fell 956.11% to $10.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $10.6 million, marking a year-over-year decrease of 956.11%. This contributed to the annual value of $13.7 million for FY2023, which is 1147.28% down from last year.
- As of Q3 2024, SELLAS Life Sciences' Total Current Liabilities stood at $10.6 million, which was down 956.11% from $12.0 million recorded in Q2 2024.
- SELLAS Life Sciences' Total Current Liabilities' 5-year high stood at $15.5 million during Q4 2022, with a 5-year trough of $3.6 million in Q1 2020.
- Over the past 5 years, SELLAS Life Sciences' median Total Current Liabilities value was $11.7 million (recorded in 2023), while the average stood at $9.9 million.
- In the last 5 years, SELLAS Life Sciences' Total Current Liabilities plummeted by 5961.41% in 2021 and then surged by 21142.11% in 2022.
- SELLAS Life Sciences' Total Current Liabilities (Quarter) stood at $12.3 million in 2020, then plummeted by 59.61% to $5.0 million in 2021, then surged by 211.42% to $15.5 million in 2022, then decreased by 11.47% to $13.7 million in 2023, then fell by 22.73% to $10.6 million in 2024.
- Its last three reported values are $10.6 million in Q3 2024, $12.0 million for Q2 2024, and $14.4 million during Q1 2024.